 BioTelemetry gained as much as 18 on Friday after news that the cardiac-diagnostics firm will be acquired by Dutch company Royal Philips for 2.8 billion. BioTelemetry is a Pennsylvania-based medical company that makes equipment that remotely diagnoses and monitors cardiac activity. 